30 Day Trial

Integra LifeSciences 2Q17 Orthopaedic Revenue


ORTHOWORLD estimates Integra LifeSciences’ 2Q17 orthopaedic revenue at US $37.3MM, +34.1% from 2Q16, and 1H17 revenue of $68.5MM, +27.1% vs. 1H16.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.